| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.0069 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.0051 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |